SHCBP1 and central nervous system cancer: By analyzing the expression of CEP55 and SHCBP1 in glioma patients and its correlations to patient prognosis, we found higher expression of CEP55 and SHCBP1 in glioma tissues than in nonmalignant tissue (Figures 4(a) and 4(b)) and increased expression with increased glioma grade (Figures 4(c) and 4(d)), and survival analysis found that patients with low CEP55 and SHCBP1 expression had better prognoses (Figures 4(e) and 4(f)).